Travere Therapeutics Stock Forecast

Buy or Hold candidate since Apr 15, 2026 Gain 11.87%

The Travere Therapeutics, Inc. stock price fell by -0.80% on the last day (Friday, 5th Jun 2026) from $46.18 to $45.81. During the last trading day the stock fluctuated 5.45% from a day low at $45.30 to a day high of $47.77. The price has fallen in 6 of the last 10 days but is still up by 2.39% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 0 shares were bought and sold for approximately $0 .

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $43.35 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 71.46% during the next 3 months and, with a 90% probability hold a price between $74.33 and $95.65 at the end of this 3-month period.

TVTX Signals & Forecast

The Travere Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $45.73 and $43.33. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, June 04, 2026, and so far it has fallen -0.80%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Travere Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $42.66 and $42.13. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Travere Therapeutics, Inc. finds support just below today's level at $42.66. If this is broken, then the next support from accumulated volume will be at $42.13 and $39.54.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $2.47 between high and low, or 5.45%. For the last week the stock has had daily average volatility of 5.45%

Our recommended stop-loss: $43.93 (-4.10%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (TVTX) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Travere Therapeutics, Inc. to open at $46.29, and during the day (based on 14 day Average True Range), to move between $44.70 and $46.92, which gives a possible trading interval of +/-$2.23 (+/-4.99%) up or down from last closing price. If Travere Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 4.99% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $46.18 (0.81%) than the support at $42.66 (6.88%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Travere Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Travere Therapeutics, Inc. stock to perform well in the short-term.

Current score: 2.150 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $46.29 ( 1.06%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk